Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-27

FDA Approved: ETRAVIRINE — Supplemental Application (Patriot Pharmaceuticals)

View source ↗

Summary

FDA approves a supplemental NDA for Etravirine submitted by Patriot Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • etravirine (etravirine)

Snippet

SUPPL AP for ETRAVIRINE (ETRAVIRINE)